Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2018, Vol. 38 Issue (2): 116-125    DOI: 10.13523/j.cb.20180217
Orginal Article     
Global Patent Analysis and Technology Prospect of Genetically Modified Soybean
You-hua WANG1,Jing-jing CAI1,Ming YANG2,Tian ZHANG3,Hong-mei REN3,Wan-nong ZOU1,Guo-qing SUN1*()
1 Biotechnology Research Institute, Chinese Academy of Agricultural Sciences, Beijing 100081, China
2 General Office of Chinese Academy of Sciences, Beijing 100049, China
3 National Science Library, Chinese Academy of Sciences, Beijing 100190, China
Download: HTML   PDF(1427KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

As the most widely planted crops, genetically modified soybean plays an important role in the guarantee of human oil and feed supply. By using the method of patent analysis, a statistical research on the patent documents from PatSnap database in the field of genetically modified soybean in 1985~2016 was accomplished, the results showed the overall development trend of the global soybean patents, the research hot spot and the technology distribution and pattern. A comparative analysis of the competitiveness of China’s soybean research and development was also carried out. The future of soybean industry development was finally put forward.



Key wordsGlobal      Genetically modified soybean      Patent     
Received: 13 July 2017      Published: 21 March 2018
ZTFLH:  Q819  
Cite this article:

You-hua WANG,Jing-jing CAI,Ming YANG,Tian ZHANG,Hong-mei REN,Wan-nong ZOU,Guo-qing SUN. Global Patent Analysis and Technology Prospect of Genetically Modified Soybean. China Biotechnology, 2018, 38(2): 116-125.

URL:

https://manu60.magtech.com.cn/biotech/10.13523/j.cb.20180217     OR     https://manu60.magtech.com.cn/biotech/Y2018/V38/I2/116

Fig.1 The annual distribution of transgenic soybean patents application and disclosure from 1985~2016
序号 IPC分类号 专利数 涉及技术领域
1 C12N15 8766 突变或遗传工程;遗传工程涉及的DNA或RNA,载体(如质粒)或其分离、制备或纯化;所使用的宿主
2 A01H5 5844 有花植物,即被子植物
3 C07K14 3141 20个氨基酸以上的肽
4 C12N5 2908 未分化的人类、动物或植物细胞,如细胞系;组织及它们的培养或维持
5 C12N9 2873 酶;酶原及其组合物,制备、活化、抑制、分离或纯化酶的方法
6 A01H1 2047 改良基因型的方法
7 C07H21 1356 含有两个或多个单核苷酸单元的化合物,具有以核苷基的糖化物基团连接的单独的磷酸酯基或多磷酸酯基,例如核酸
8 C12Q1 1296 包含酶或微生物的测定或检验方法;其组合物及这种组合物的制备方法
9 C12N1 1149 微生物本身,如原生动物;及其组合物;繁殖、维持或保藏微生物或其组合物的方法;制备或分离含有一种微生物的组合物的方法;及其培养基
10 A01N43 575 含有杂环化合物的杀生剂、害虫驱避剂或引诱剂,或植物生长调节剂
Table1 Main technical distribution of transgenic soybean patents
Fig.2 Annual analysis of transgenic soybean patent applications in key IPC technology areas
Fig.3 Analysis of main countries and regions for transgenic soybean patents application
Fig.4 Patent applications for transgenic soybeans in different countries
Fig.5 Annual patent applications for transgenic soybeans in different countries
Fig.6 Technology focus and application layout in different countries
排名 申请人 专利数 百分比 总部所在
国家/地区
1 孟山都 1290 11.30% 美国
2 先锋种业 1260 11.04% 美国
3 巴斯夫 1002 8.78% 德国
4 杜邦 697 6.11% 美国
5 陶氏农业科学公司 640 5.61% 美国
6 先正达 347 3.04% 瑞士
7 阿森尼克斯公司 293 2.57% 美国
8 拜耳 277 2.43% 德国
12 中国科学院 95 0.83% 中国
15 中国农业科学院 70 0.61% 中国
19 大北农 58 0.51% 中国
Table 2 Key transgenic soybean patent applicants
Fig.7 Patent acceptance of China Intellectual Property Office
Fig.8 Comparative analysis of development strategy and competition of major R & D units
年份 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016
大北农集团 0 0 0 0 0 0 0 11 20 6 7 14
中国农业科学院 5 2 0 5 1 9 6 7 13 7 7 4
Table 3 The trend of transgenic soybean patent application by DBN group and CAAS
[1]   ISAAA. 2016年全球生物技术/转基因作物商业化发展态势. 中国生物工程杂志, 2017,37(4):1-8.
doi: 10.13523/j.cb.20170401
[1]   ISAAA. Commercial development of global biotechnology / genetically modified crops China Biotechnology, 2017,37(4):1-8.
doi: 10.13523/j.cb.20170401
[2]   崔宁波, 张正岩 . 转基因大豆研究及应用进展. 西北农业学报, 2016,25(8):1111-1124.
[2]   Cui N B, Zang Z Y . Advance of research and application of transgenic soybean. Acta Agriculturae Boreali-occidentalis Sinica, 2016,25(8):1111-1124.
[3]   程景民, 卞亚楠 . 基于CiteSpace的转基因大豆研究热点分析. 中国农业信息, 2016,28(24):72-74.
[3]   Cheng J M, Bian Y N . Analysis of the research hotspots in genetically modified soybean based on CiteSpace China Agricultural Information, 2016,28(24):72-74.
[4]   王戴尊, 魏阙, 单美玉 , 等. 基于Innography的转基因大豆专利分析. 农业图书情报学刊, 2016,28(9):40-45.
doi: 10.13998/j.cnki.issn1002-1248.2016.09.010
[4]   Wang D Z, Wei Q, Shan M Y , et al. Patent analysis of transgenic soybean technology based on Innography Journal of Library and Information Sciences in Agriculture, 2016,28(9):40-45.
doi: 10.13998/j.cnki.issn1002-1248.2016.09.010
[5]   赵霞, 王玉光, 胡瑞法 . 基于专利分析的转基因农作物技术布局态势研究. 情报杂志, 2014,33(9):51-55,92.
doi: 10.3969/j.issn.1002-1965.2014.09.010
[5]   Zhao X, Wang Y G, Hu R F . Patent layout and status analysis of genetically modified crop technology Journal of Intelligence, 2014,33(9):51-55,92.
doi: 10.3969/j.issn.1002-1965.2014.09.010
[6]   吴学彦, 韩雪冰, 戴磊 . 基于DII的转基因大豆领域专利计量分析. 中国生物工程杂志, 2013,33(3):143-148.
[6]   Wu X Y, Han X B, Dai L . Patentometric analysis of transgenic soybean technology based on DII China Biotechnology, 2013,33(3) : 143-148.
[7]   李菊丹 . 论我国植物发明专利保护制度的完善——兼论专利制度与植物新品种保护制度的关系. 河北法学, 2017,35(4):2-18.
doi: 10.16494/j.cnki.1002-3933.2017.04.001
[7]   Li J D . Study on the improvement of plant invention patent protection system in China——Study on the relation between patent and plant variety right Hebei Law Science, 2017,35(4):2-18.
doi: 10.16494/j.cnki.1002-3933.2017.04.001
[8]   彭玉勇 . 欧美对植物及新品种的专利保护. 中国发明与专利, 2004,1(10):74-75.
[8]   Peng Y L . Patent protection of plants and new varieties in Europe and America Chinese Inventions and Patents 2004,1(10):74-75.
[9]   苗润莲 . 基于专利分析的转基因大豆技术现状研究. 大豆科学, 2015,34(4):723-730.
[9]   Miao R L . Study on genetically modified soybean technology development status based on patent analysis Soybean Science, 2015,34(4):723-730.
[10]   谭龙, 刘云 . 从制度变革看中国专利申请量的增长. 科技进步与对策, 2014,31(2):113-117.
doi: 10.6049/kjjbydc.2013030003
[10]   Tang L, Liu Y . The growth of China’s patent applications from the perspective of institutional change Science & Technology Progress and Policy, 2014,31(2):113-117.
doi: 10.6049/kjjbydc.2013030003
[11]   林落 . 基因编辑“进军”农业育种. 科学新闻, 2016,18(12):71-73.
[11]   Lin L . Gene editing “march” agricultural breeding Science News, 2016,18(12):71-73.
[12]   Sun X, Hu Z, Chen R , et al. Targeted mutagenesis in soybean using the CRISPR-Cas9 system. Scientific Rep, 2015,5:10342.
doi: 10.1038/srep10342
[13]   张玲, 张原宇, 李启云 , 等. 大豆种子蛋白表达系统的开发与研究前景. 大豆科学, 2014,33(4):616-618.
doi: 10.11861/j.issn.1000-9841.2014.04.0616
[13]   Zhang L, Zhang Y Y, Li Q Y , et al. The research and development prospects of soybean seed protein expression system Soybean Science, 2014,33(4):616-618.
doi: 10.11861/j.issn.1000-9841.2014.04.0616
[14]   余永亮, 梁慧珍, 王树峰 , 等. 中国转基因大豆的研究进展及其产业化. 大豆科学, 2010,29(1):143-150.
[14]   Yu Y L, Liang H Z, Wang S F , et al. Research progress and commercialization on transgenic soybean in China Soybean Science, 2010,29(1):143-150.
[15]   陈洁君, 张维, 宛煜嵩 , 等. 全球转基因作物发展现状及趋势. 农业生物技术学报, 2011,19(2):369-374.
doi: 10.3969/j.issn.1674-7968.2011.02.025
[15]   Chen J J, Zhang W, Wan Y S , et al. Situation and tendency of the global genetically modified crops in development Journal of Agricultural Biotechnology, 2011,19(2):369-374.
doi: 10.3969/j.issn.1674-7968.2011.02.025
[16]   Su Y, Xu L, Xu P . Current status and trends of commercial transgenic crops in the world. Biotechnology & Business, 2011,19(2):369-374.
[17]   Zhang C, Hou Y, Hao Q , et al. Genome-wide survey of the soybean GATA transcription factor gene family and expression analysis under low nitrogen stress. PloS One, 2015,10(4):e0125174.
doi: 10.1371/journal.pone.0125174 pmid: 25886477
[18]   王彪, 张鑫, 卢欣欣 , 等. 上海交通大学.一种提高大豆含硫氨基酸含量及降低过敏原蛋白的方法 . 中国: 发明专利,106480089A. 2016-12-30.
[18]   Wang B, Zhang X, Lu X X , et al. A method for increasing sulfur-containing amino acid content of soybean and reducing allergen protein. China:China Invention Patent, 106480089A. 2016-12-30
[1] CHEN Ying,LI Qian. Patent Analysis on the Development Trend of Industrial Application of Special Yeast[J]. China Biotechnology, 2021, 41(4): 91-99.
[2] JIANG Tian,ZHANG Chao,LIU Hui-zhou. Development Trends Analysis of Microbial Fuel Cell[J]. China Biotechnology, 2020, 40(1-2): 189-197.
[3] XIE Hua-ling,LV Lu-cheng,YANG Yan-ping. Patent Analysis of Global Coronavirus Vaccine[J]. China Biotechnology, 2020, 40(1-2): 57-64.
[4] ZHAO Ping,YANG Yan-ping. Patent Situation Analysis of Diagnosis Technology for Coronavirus Infection in Human[J]. China Biotechnology, 2020, 40(1-2): 51-56.
[5] LI Dong-qiao,LV Lu-cheng,YANG Yan-ping. The Research Status and Development Trend of Global Human Coronavirus Antibody Field[J]. China Biotechnology, 2020, 40(1-2): 65-70.
[6] HUANG Peng-fei,CHEN Yun,LU Jiao,MAO Kai-yun,YUAN Yin-chi. Development Situation and Suggestions of Biomedicine Patent-intensive Industry, Based on the Case Study of Shanghai[J]. China Biotechnology, 2020, 40(12): 108-116.
[7] ZHAO Jian-min,ZHANG Si-yuan. Review of Patented Bacteriophage Treatment Technology for Drug-Resistant Bacteria Infection[J]. China Biotechnology, 2020, 40(10): 104-111.
[8] Jing REN,Wan-nong ZOU,Min SONG. Research on the Changing Trend of the New Pattern of International Seed Industry Competition Formed by the Merger of Multinational Seed Industry Companies——Take Intellectual Property as an Example[J]. China Biotechnology, 2019, 39(7): 108-117.
[9] Hua-ling XIE,Dong-qiao LI,Pei-juan CHI,Yan-ping YANG. An Analysis on the Competition of Patents in Synthetic Biology[J]. China Biotechnology, 2019, 39(4): 114-123.
[10] WANG You-hua,ZOU Wan-nong,LIU Xiao-qing,WANG Zhaohua,SUN Guo-qing. Global Patent Analysis and Technology Prospect of Genetically Modified Maize[J]. China Biotechnology, 2019, 39(12): 83-94.
[11] Yue-lei FAN,Jiao LU,Da-ming CHEN,Kai-yun MAO. Strategies for Stem Cell Patent Evaluation and Patent Transfer and Transformation[J]. China Biotechnology, 2019, 39(1): 99-106.
[12] Ping ZHAO,Bo ZHANG,Xue-zhao WANG. Patent Situation Analysis in Agricultural Biotechnology Field[J]. China Biotechnology, 2018, 38(8): 100-107.
[13] Qing BI,Lin SUN. Analysis and Comparison of Foreign and Chinese Patent Applications in Chimeric Antigen Receptor T Cell (CAR-T) Technology[J]. China Biotechnology, 2018, 38(4): 107-114.
[14] LI Min, WU Ri-wei. The Analysis of Coagulation Factors Market[J]. China Biotechnology, 2017, 37(5): 133-139.
[15] LI Min, WU Ri-wei. Overview on the Antineoplastic Drugs Market[J]. China Biotechnology, 2017, 37(4): 125-133.